Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vallon Pharmaceuticals, Inc.

0.4000
0.0000
Volume:- -
Turnover:- -
Market Cap:10.69M
PE:-0.02
High:0.4000
Open:0.4000
Low:0.4000
Close:0.4000
Loading ...
Jul 07, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 27, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 02, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 25, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Apr 25, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 25, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 21, 2023

Major Issues Report

8-K - Current report
Apr 21, 2023

Major Issues Report

8-K - Current report
Apr 12, 2023

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 12, 2023

Major Issues Report

8-K - Current report
Apr 07, 2023

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 07, 2023

Major Issues Report

8-K - Current report
Apr 04, 2023

Major Issues Report

8-K - Current report
Apr 04, 2023

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Correspondence

CORRESP [Cover] - Correspondence